New AAM CEO: Traditional Lobbying On Lowering Health Care Costs Can Mix With COVID-19 Talks

 
• By Derrick Gingery

Dan Leonard is working on post-pandemic generic drug issues, using coronavirus as a way to get in front of lawmakers.

3D render of generic pill with granules over white background - Illustration
New AAM President and CEO Dan Leonard wants generics sponsors to be proud of their work maintaining the supply chain during the pandemic. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics